↧
A Stifled U.S. Biotech Sector: Is it Too Late to Recover?
BOSTON ‑ Amid all of the excitement that comes with the biopharma industry’s largest annual gathering in Boston this week, I’m worried about the future. The U.S. has lost too much ground ‑ due to the...
View ArticleMystic moldy pizza: Food for thought from Allicense 2014
SAN FRANCISCO – When talking trends in biopharma there’s no shortage of metaphors – Tuesday’s health care debate, for example, went for the timely baseball terms, referencing singles and home runs – or...
View Article